Literature DB >> 10996283

Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety.

W H Peng1, M T Hsieh, Y S Lee, Y C Lin, J Liao.   

Abstract

The aim of the present study was to investigate the ethanolic extract of Semen Ziziphi jujuba (SZJE) induced anxiolytic effect. The SZJE was orally administered to male ICR mice, at 0.5, 1.0 and 2. 0 g/kg, 30 min before the behavioral evaluation in the black and white test (BWT) and elevated plus maze (EPM). The SZJE at the dosage 0.5-2.0 g/kg increased the first time entry, total changes and times spent in the white chamber of the BWT. The SZJE at the dosage 0.5-1.0 g/kg increased the percentage of time-spent and the percentage of arm entries in the open arms of the EPM and decreased the percentage of time-spent and the percentage of arm entries in the closed arms of the EPM. Furthermore, the SZJE at the dosage of 1. 0 g/kg prolonged the hexobarbital-induced sleeping time in mice and decreased the locomotor activity in rats. These results suggested that SZJE possessed anxiolytic effect at lower dose and sedative effect at higher dose.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996283     DOI: 10.1016/s0378-8741(00)00255-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  28 in total

1.  GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment.

Authors:  Ravid Doron; Avital Sever; Assaf Handelsman; Roni Toledano; Motty Franko; Yafit Hirshler; Alon Shamir; Or Burstein; Moshe Rehavi
Journal:  J Mol Neurosci       Date:  2018-05-08       Impact factor: 3.444

Review 2.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

Review 3.  Was Hawan Designed to Fight Anxiety-Scientific Evidences?

Authors:  R K Romana; A Sharma; V Gupta; R Kaur; S Kumar; P Bansal
Journal:  J Relig Health       Date:  2020-02

Review 4.  Awareness and current knowledge of epilepsy.

Authors:  Asmat Ullah Khan; Muhammad Akram; Muhammad Daniyal; Naheed Akhter; Muhammad Riaz; Naheed Akhtar; Mohammad Ali Shariati; Fozia Anjum; Samreen Gul Khan; Abida Parveen; Saeed Ahmad
Journal:  Metab Brain Dis       Date:  2019-10-11       Impact factor: 3.584

5.  An aqueous macerate of Ziziphus jujuba reduces long-term spatial memory impairment in D-galactose treated rats: role of anti-inflammatory pathways.

Authors:  Antoine Kavaye Kandeda; Danide Nguedia; Etienne Djeuzong; Jonas Kouamouo; Théophile Dimo
Journal:  Metab Brain Dis       Date:  2022-08-04       Impact factor: 3.655

6.  Anxiolytic and antidepressants' effect of Crataegus pinnatifida (Shan Zha): biochemical mechanisms.

Authors:  Keren Nitzan; Dekel David; Motty Franko; Roni Toledano; Sharon Fidelman; Yaarit Simchon Tenenbaum; Maya Blonder; Shir Armoza-Eilat; Alon Shamir; Moshe Rehavi; Yair Ben-Chaim; Ravid Doron
Journal:  Transl Psychiatry       Date:  2022-05-19       Impact factor: 7.989

7.  Anxiolytic-like effects of compound zhi zhu xiang in rats.

Authors:  Yan-Li Wang; Jin-Li Shi; Liu Yong; Zhao Ren; Yu-Jing Zhai; Jian-You Guo
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-29       Impact factor: 2.629

8.  Molecular Regulation of Betulinic Acid on α3β4 Nicotinic Acetylcholine Receptors.

Authors:  Shinhui Lee; Woog Jung; Sanung Eom; Hye Duck Yeom; Heui-Dong Park; Junho H Lee
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

9.  Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling.

Authors:  Zaixiong Ji; Jiaqi Li; Jianbo Wang
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

10.  Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002.

Authors:  Fang-Pey Chen; Maw-Shiou Jong; Yu-Chun Chen; Yen-Ying Kung; Tzeng-Ji Chen; Fun-Jou Chen; Shinn-Jang Hwang
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.